18-907729-G-T

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001099733.2(ADCYAP1):​c.181G>T​(p.Ala61Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000124 in 1,529,642 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000066 ( 0 hom., cov: 34)
Exomes 𝑓: 0.0000065 ( 0 hom. )

Consequence

ADCYAP1
NM_001099733.2 missense

Scores

17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.139
Variant links:
Genes affected
ADCYAP1 (HGNC:241): (adenylate cyclase activating polypeptide 1) This gene encodes a secreted proprotein that is further processed into multiple mature peptides. These peptides stimulate adenylate cyclase and increase cyclic adenosine monophosphate (cAMP) levels, resulting in the transcriptional activation of target genes. The products of this gene are key mediators of neuroendocrine stress responses. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.053658634).
BS2
High AC in GnomAd4 at 10 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADCYAP1NM_001099733.2 linkc.181G>T p.Ala61Ser missense_variant Exon 3 of 5 ENST00000450565.8 NP_001093203.1 P18509
ADCYAP1NM_001117.5 linkc.181G>T p.Ala61Ser missense_variant Exon 2 of 4 NP_001108.2 P18509
ADCYAP1XM_005258081.5 linkc.598G>T p.Ala200Ser missense_variant Exon 4 of 6 XP_005258138.2 B7Z222
ADCYAP1XM_047437288.1 linkc.181G>T p.Ala61Ser missense_variant Exon 3 of 5 XP_047293244.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADCYAP1ENST00000450565.8 linkc.181G>T p.Ala61Ser missense_variant Exon 3 of 5 1 NM_001099733.2 ENSP00000411658.3 P18509
ADCYAP1ENST00000579794.1 linkc.181G>T p.Ala61Ser missense_variant Exon 2 of 4 1 ENSP00000462647.1 P18509
ADCYAP1ENST00000269200.5 linkn.179G>T non_coding_transcript_exon_variant Exon 1 of 3 2
ENSG00000265671ENST00000582554.1 linkn.-49C>A upstream_gene_variant 5

Frequencies

GnomAD3 genomes
AF:
0.0000657
AC:
10
AN:
152110
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000653
AC:
9
AN:
1377532
Hom.:
0
Cov.:
41
AF XY:
0.00000588
AC XY:
4
AN XY:
680624
show subpopulations
Gnomad4 AFR exome
AF:
0.0000336
Gnomad4 AMR exome
AF:
0.0000291
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000254
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000371
Gnomad4 OTH exome
AF:
0.0000174
GnomAD4 genome
AF:
0.0000657
AC:
10
AN:
152110
Hom.:
0
Cov.:
34
AF XY:
0.0000808
AC XY:
6
AN XY:
74302
show subpopulations
Gnomad4 AFR
AF:
0.000241
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000416

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Sep 27, 2024
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.181G>T (p.A61S) alteration is located in exon 3 (coding exon 2) of the ADCYAP1 gene. This alteration results from a G to T substitution at nucleotide position 181, causing the alanine (A) at amino acid position 61 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.092
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
9.8
DANN
Benign
0.97
DEOGEN2
Benign
0.19
T;T
Eigen
Benign
-0.98
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.11
N
LIST_S2
Benign
0.69
.;T
M_CAP
Benign
0.016
T
MetaRNN
Benign
0.054
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.6
L;L
PrimateAI
Benign
0.31
T
REVEL
Benign
0.019
Sift4G
Benign
0.77
T;T
Polyphen
0.21
B;B
Vest4
0.13
MutPred
0.25
Gain of glycosylation at A61 (P = 0);Gain of glycosylation at A61 (P = 0);
MVP
0.53
MPC
0.60
ClinPred
0.081
T
GERP RS
-0.088
Varity_R
0.065
gMVP
0.36

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs966506984; hg19: chr18-907730; API